Literature DB >> 6287470

Regulation of the in vitro antibody response by neuroendocrine hormones.

H M Johnson, E M Smith, B A Torres, J E Blalock.   

Abstract

Treatment of lymphocytes with inducers of interferon alpha (IFN-alpha) results in the production of corticotropin (ACTH) and endorphin-like activities. The pro-opiomelanocortin-derived hormones ACTH and alpha-, beta-, and gamma-endorphin and the structurally related hormones [Leu]- and [Met]enkephalin were therefore tested for their effects on the in vitro antibody response of mouse spleen cells. ACTH and alpha-endorphin were potent inhibitors (>/=80% suppression) of the antibody response to the T-cell-dependent antigen sheep erythrocytes at a concentration of 0.5 muM. [Met]- and [Leu]enkephalin were moderate inhibitors (approximately 60% suppression) at 0.2-2 muM, and beta- and gamma-endorphin were minimal inhibitors (approximately 20% suppression) at 5-6 muM. At higher concentrations ACTH also inhibited the antibody response to the T-cell-independent antigen dinitrophenyl-Ficoll, suggesting that T-cell function was more sensitive to blockage by these hormones than was B-cell function. ACTH and IFN had similar suppression properties; thus, the hormone-like activities associated with IFN-alpha may play a role in IFN-induced immunosuppression. alpha-Endorphin immunosuppression was blocked by naloxone, which suggested that alpha-endorphin exerted its effects through binding to opiate-like receptors on the spleen cells. The failure of beta-endorphin to suppress the immune response significantly was not due to its failure to bind to the opiate-like receptors because it blocked alpha-endorphin-induced suppression. Direct evidence for both opiate and ACTH receptors on the spleen cells was obtained in binding studies with labeled enkephalin and ACTH. Such studies revealed the presence of both high- and low-affinity receptors. The data show that neuroendocrine polypeptide hormones can regulate the immune response.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287470      PMCID: PMC346599          DOI: 10.1073/pnas.79.13.4171

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Interferon inhibition of the primary in vitro antibody response to a thymus-independent antigen.

Authors:  H M Johnson; J A Bukovic; S Baron
Journal:  Cell Immunol       Date:  1975-11       Impact factor: 4.868

2.  Inhibition of the primary in vitro antibody response by interferon preparations.

Authors:  H M Johnson; B G Smith; S Baron
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

3.  Immune conservation: a possible consequence of the mechanism of interferon-induced antibody suppression.

Authors:  R J Booth; J M Booth; J Marbrook
Journal:  Eur J Immunol       Date:  1976-11       Impact factor: 5.532

4.  Studies on the binding of 125I-labelled corticotrophin to isolated rat adrenocortical cells.

Authors:  R A McIlhinney; D Schulster
Journal:  J Endocrinol       Date:  1975-01       Impact factor: 4.286

5.  Macrophage requirement for the in vitro response to TNP Ficoll: a thymic independent antigen.

Authors:  T M Chused; S S Kassan; D E Mosier
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

6.  Beta-lipotropin and endorphins: implications of current knowledge.

Authors:  R Guillemin
Journal:  Hosp Pract       Date:  1978-11

7.  Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins.

Authors:  J E Blalock; E M Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

8.  Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon.

Authors:  E M Smith; J E Blalock
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Common pathways of interferon and hormonal action.

Authors:  J E Blalock; J D Stanton
Journal:  Nature       Date:  1980-01-24       Impact factor: 49.962

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  46 in total

1.  Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes.

Authors:  Eric M Smith; Mike Gregg; Farhad Hashemi; Liesl Schott; Thomas K Hughes
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

Review 2.  Interleukins and neurohormones: a common language.

Authors:  R Knight; N Sarlis; A Stephanou
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

3.  ACTH enhancement of T-lymphocyte cytotoxic responses.

Authors:  Eve W Johnson; Thomas K Hughes; Eric M Smith
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

4.  Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro.

Authors:  R P Saneto; A Altman; R L Knobler; H M Johnson; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis.

Authors:  Eric M Smith
Journal:  Brain Behav Immun       Date:  2007-09-27       Impact factor: 7.217

Review 6.  Retinoids and the control of growth/death decisions in human neuroblastoma cell lines.

Authors:  G Melino; C J Thiele; R A Knight; M Piacentini
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

Review 7.  Opioids and exercise. An update.

Authors:  G A Sforzo
Journal:  Sports Med       Date:  1989-02       Impact factor: 11.136

8.  The influence of regular physical activity on the cell-mediated immunity in pigs.

Authors:  M Jensen
Journal:  Acta Vet Scand       Date:  1989       Impact factor: 1.695

9.  Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins.

Authors:  D Harbour-McMenamin; E M Smith; J E Blalock
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

10.  Evidence for an inhibitory role of beta-endorphin and other opioids on human total T rosette formation.

Authors:  C De Carolis; G De Sanctis; R Perricone; C Moretti; A Fabbri; L Gnessi; F Fraioli; L Fontana
Journal:  Experientia       Date:  1984-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.